HRT Financial’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$151K Buy
96,866
+85,126
+725% +$108K ﹤0.01% 3967
2026
Q2
$13K Buy
+11,740
New +$14.1K ﹤0.01% 3963
2025
Q4
– Sell
-20,330
Closed -$34K – 3213
2025
Q3
$34K Buy
+20,330
New +$64.6K ﹤0.01% 2639
2024
Q2
– Sell
-350
Closed -$23K – 2257
2024
Q1
$23K Buy
+350
New +$26.1K ﹤0.01% 1997
2023
Q3
– Sell
-81
Closed -$29K – 2425
2023
Q2
$29K Buy
81
+63
+350% +$28.4K ﹤0.01% 2067
2023
Q1
$12K Buy
+18
New +$16K ﹤0.01% 2234
2022
Q2
– Sell
-46
Closed -$70K – 2963
2022
Q1
$70K Buy
46
+29
+171% +$39.1K ﹤0.01% 2713
2021
Q4
$31K Buy
+17
New +$45.5K ﹤0.01% 2901
2021
Q2
– Sell
-1,552
Closed -$7.52M – 2866
2021
Q1
$7.52M Buy
+1,552
New +$8.75M 0.08% 187

Other funds holding BNGO

HRT Financial's BNGO Position: Q3 2026 in Review

HRT Financial increased its Bionano Genomics (BNGO) stake by 725% in Q3 2026, buying an estimated $108K and bringing the position to 96,866 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #3967.

HRT Financial first reported a position in BNGO in Q1 2021 and has held it in 9 quarters since. The position peaked at $7.52M in Q1 2021. 37 funds tracked by Wall St. Rank hold BNGO as of Q3 2026.

  • HRT Financial held 96,866 shares of Bionano Genomics worth $151K as of Q3 2026.
  • HRT Financial bought 85,126 Bionano Genomics shares in Q3 2026, an estimated $108K.
  • Bionano Genomics made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #3967 holding.
  • HRT Financial first reported a position in Bionano Genomics in Q1 2021 and has held it in 9 quarters since.
  • HRT Financial's Bionano Genomics position peaked at $7.52M in Q1 2021.
  • 37 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.